Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 17 | 2025 | 503 | 3.680 |
Why?
|
| Ethanol | 9 | 2025 | 221 | 3.560 |
Why?
|
| Liver Diseases, Alcoholic | 5 | 2025 | 9 | 2.600 |
Why?
|
| Receptors, Steroid | 5 | 2024 | 37 | 2.070 |
Why?
|
| Obesity | 6 | 2024 | 1131 | 1.500 |
Why?
|
| Mice, Knockout | 10 | 2024 | 1010 | 1.320 |
Why?
|
| Inflammation | 5 | 2024 | 729 | 1.310 |
Why?
|
| Hepatocytes | 4 | 2015 | 79 | 1.290 |
Why?
|
| Retinoid X Receptor alpha | 5 | 2009 | 8 | 1.180 |
Why?
|
| Mice | 22 | 2025 | 6490 | 1.060 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 1804 | 1.040 |
Why?
|
| Estrogen Receptor alpha | 2 | 2025 | 120 | 0.980 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 52 | 0.840 |
Why?
|
| Oxidative Stress | 4 | 2025 | 990 | 0.790 |
Why?
|
| Animals | 26 | 2025 | 16695 | 0.770 |
Why?
|
| Methionine | 3 | 2008 | 27 | 0.640 |
Why?
|
| Fatty Liver, Alcoholic | 2 | 2017 | 2 | 0.630 |
Why?
|
| Choline Deficiency | 2 | 2008 | 4 | 0.580 |
Why?
|
| Fatty Liver | 4 | 2024 | 71 | 0.530 |
Why?
|
| Up-Regulation | 2 | 2017 | 534 | 0.510 |
Why?
|
| Male | 19 | 2025 | 22779 | 0.500 |
Why?
|
| Dietary Fats | 2 | 2014 | 117 | 0.480 |
Why?
|
| Cytochrome P-450 CYP2E1 | 4 | 2024 | 24 | 0.470 |
Why?
|
| Balanophoraceae | 2 | 2004 | 2 | 0.440 |
Why?
|
| Female | 11 | 2025 | 24018 | 0.410 |
Why?
|
| Tannins | 2 | 2004 | 10 | 0.410 |
Why?
|
| Hydrolyzable Tannins | 2 | 2004 | 20 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2010 | 66 | 0.390 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 658 | 0.390 |
Why?
|
| Glucose | 1 | 2013 | 242 | 0.370 |
Why?
|
| Atherosclerosis | 2 | 2024 | 164 | 0.370 |
Why?
|
| Gene Expression Regulation | 5 | 2024 | 1066 | 0.360 |
Why?
|
| Signal Transduction | 3 | 2025 | 2111 | 0.320 |
Why?
|
| Adipose Tissue, White | 2 | 2024 | 18 | 0.320 |
Why?
|
| Sex Factors | 2 | 2025 | 1008 | 0.320 |
Why?
|
| Antioxidants | 2 | 2004 | 439 | 0.310 |
Why?
|
| Cholestasis | 1 | 2009 | 11 | 0.300 |
Why?
|
| RNA, Messenger | 6 | 2017 | 1265 | 0.300 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 141 | 0.290 |
Why?
|
| Mixed Function Oxygenases | 2 | 2005 | 31 | 0.280 |
Why?
|
| Pyrimidines | 1 | 2009 | 130 | 0.280 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2005 | 51 | 0.280 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2025 | 89 | 0.270 |
Why?
|
| Glutathione Transferase | 2 | 2005 | 90 | 0.270 |
Why?
|
| Cytokines | 2 | 2009 | 661 | 0.260 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 1554 | 0.260 |
Why?
|
| Membrane Proteins | 2 | 2024 | 548 | 0.240 |
Why?
|
| Lipids | 1 | 2007 | 256 | 0.240 |
Why?
|
| Plants, Medicinal | 2 | 2004 | 60 | 0.240 |
Why?
|
| Diet | 2 | 2008 | 810 | 0.230 |
Why?
|
| Ovariectomy | 1 | 2025 | 128 | 0.230 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2024 | 18 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2024 | 55 | 0.210 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2004 | 99 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 167 | 0.200 |
Why?
|
| Weight Gain | 1 | 2024 | 138 | 0.200 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 457 | 0.190 |
Why?
|
| Hepatomegaly | 2 | 2013 | 4 | 0.180 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2015 | 10 | 0.180 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 76 | 0.180 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 38 | 0.180 |
Why?
|
| Autophagy | 2 | 2020 | 136 | 0.170 |
Why?
|
| Proteins | 1 | 2024 | 383 | 0.170 |
Why?
|
| Plant Extracts | 1 | 2004 | 303 | 0.170 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 190 | 0.170 |
Why?
|
| Humans | 11 | 2025 | 42163 | 0.160 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 143 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2023 | 324 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 160 | 0.150 |
Why?
|
| Bile Acids and Salts | 2 | 2009 | 37 | 0.150 |
Why?
|
| Receptors, Notch | 1 | 2018 | 37 | 0.140 |
Why?
|
| Liver Function Tests | 2 | 2008 | 19 | 0.140 |
Why?
|
| Serotonin | 1 | 2018 | 125 | 0.140 |
Why?
|
| Lipogenesis | 1 | 2017 | 19 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 158 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 211 | 0.130 |
Why?
|
| Gene Deletion | 1 | 2017 | 168 | 0.130 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 16 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2015 | 44 | 0.120 |
Why?
|
| Isoenzymes | 2 | 2006 | 169 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 20 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2004 | 1737 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 649 | 0.110 |
Why?
|
| Glucokinase | 1 | 2013 | 3 | 0.110 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2013 | 10 | 0.110 |
Why?
|
| Hyperinsulinism | 1 | 2013 | 17 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 41 | 0.110 |
Why?
|
| Ion Channels | 1 | 2014 | 74 | 0.110 |
Why?
|
| Medicine, African Traditional | 2 | 2004 | 8 | 0.100 |
Why?
|
| PPAR alpha | 1 | 2013 | 43 | 0.100 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 112 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2015 | 253 | 0.100 |
Why?
|
| Species Specificity | 1 | 2013 | 279 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1420 | 0.100 |
Why?
|
| Microsomes, Liver | 2 | 2004 | 71 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2013 | 180 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 386 | 0.090 |
Why?
|
| Rats | 3 | 2004 | 3701 | 0.090 |
Why?
|
| Organ Size | 2 | 2008 | 167 | 0.080 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 140 | 0.080 |
Why?
|
| Endocrine System | 1 | 2010 | 12 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 585 | 0.080 |
Why?
|
| Homeostasis | 2 | 2008 | 193 | 0.080 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Steroid 12-alpha-Hydroxylase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Peroxisomes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 297 | 0.080 |
Why?
|
| Body Weight | 2 | 2008 | 428 | 0.080 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2008 | 1 | 0.070 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2008 | 14 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2008 | 56 | 0.070 |
Why?
|
| Glutathione | 2 | 2008 | 170 | 0.070 |
Why?
|
| Food, Formulated | 1 | 2008 | 4 | 0.070 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2008 | 47 | 0.070 |
Why?
|
| Hepatitis | 1 | 2008 | 11 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 64 | 0.070 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 40 | 0.070 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 72 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 116 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2008 | 134 | 0.070 |
Why?
|
| Choline | 1 | 2008 | 61 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 884 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 744 | 0.060 |
Why?
|
| Acetaminophen | 1 | 2005 | 28 | 0.060 |
Why?
|
| Genotype | 2 | 2005 | 796 | 0.060 |
Why?
|
| Ghana | 1 | 2005 | 36 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2005 | 29 | 0.060 |
Why?
|
| Gene Frequency | 1 | 2005 | 203 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 692 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2024 | 80 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 98 | 0.050 |
Why?
|
| Cytosol | 1 | 2004 | 98 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 58 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2023 | 3 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 454 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 200 | 0.050 |
Why?
|
| Thrombospondin 1 | 1 | 2023 | 23 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 221 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2002 | 23 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2023 | 180 | 0.050 |
Why?
|
| Free Radicals | 1 | 2002 | 72 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2002 | 53 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2002 | 157 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1112 | 0.040 |
Why?
|
| Time Factors | 1 | 2004 | 1848 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 518 | 0.040 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 479 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 526 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 62 | 0.040 |
Why?
|
| Smoking | 1 | 2004 | 1019 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 934 | 0.030 |
Why?
|
| Middle Aged | 2 | 2005 | 11819 | 0.020 |
Why?
|
| Aged | 1 | 2005 | 7982 | 0.020 |
Why?
|
| Adult | 2 | 2005 | 13458 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2008 | 42 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 85 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2008 | 42 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 41 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 146 | 0.020 |
Why?
|
| Cholesterol | 1 | 2008 | 230 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2005 | 5 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 661 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2004 | 7 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 458 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 187 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2004 | 587 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 287 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1266 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3942 | 0.010 |
Why?
|